Clinical Trial Update: Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports completion of ISAR-SMART-3 evaluating sirolimus- and paclitaxel-eluting stents for small coronary vessels.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Paclitaxel-eluting stent (paclitaxel-eluting stent)
• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Disease | Phase 4 | Status: COMPLETED